News

30/1/2020

Accelerating progress towards UHC at PMAC 2020

The Prince Mahidol Award Conference (PMAC) in Bangkok, an annual international conference focusing on policy-related health issues. The theme of the conference is ‘Accelerating Progress Towards Universal Health Coverage’. Read more

News

29/1/2020

Wemos endorsed the Kampala Declaration

How can we move from aid to global solidarity beyond aid? These were some of the tough questions that civil society from various countries discussed last October and November as part of the ‘Kampala Initiative’. Read more

News

24/1/2020

“A missed opportunity”: Wemos’ reaction to VIG’s code of conduct 2020

The Dutch branches of innovative pharmaceutical companies – has failed to set out a moral compass that answers urgent societal questions regarding high medicine prices and the pharmaceutical industry. Read more

News

1/1/2020

This was the year 2019: our highlights

2019 was filled with collaborations, workshops, new publications, media moments, and mutual learning sessions. And it was the anniversary year in which we looked back on 40 years of our work in protecting global public health. Read more

Blog

30/12/2019

The 2019 wins for the Access to Medicines movement

2019 was an exciting year for those who work in the field of pharmaceutical policy. The topic of access to medicines is climbing higher on the political agenda. Not just in the Netherlands. Read more

News

5/12/2019

How healthy is a ‘healthy’ economy? A closer look into SDG goals

To realise the Sustainable Development Goals (SDGs) everywhere, governments should abandon Gross Domestic Product (GDP) growth as a policy objective and place more emphasis on SDG17 on global co-operation. Read more

News

2/11/2019

Abuse of orphan designation leads to exorbitant drug price

Pharmaceutical company Lupin Europe is aiming to bring an existing medicine for a rare muscle disease on the market under a new name and at a much higher price. Read more

News

24/10/2019

Seeking a medicine system that is socially sustainable balanced

With prices of medicines skyrocketing under the current system of medicine development, the shortcomings of this R&D model are increasingly becoming clear. Read more

News

11/10/2019

Best public value for public money?

Wemos conducted a case study on the application of Dutch Official Development Assistance (ODA) policy instruments for business strengthening in the healthcare context. Read more